Company page

Nuvalent, Inc.

Nuvalent, Inc. is a public company traded under the ticker NUVL in the American market. With a market capitalization of approximately $9.75 billion, the company focuses on developing targeted therapies for cancer treatment. Nuvalent aims to address unmet medical needs through innovative drug development.